. 2019 Jul 18;26(3):297–308. doi: 10.1111/cns.13197

Table 4.

Univariate analysis of survival data

Clinical characteristics	P Value
Age, <50 y compared to >50 y	<0.0001^**
Gender, male compared to female	0.536
WHO grade, I‐II compared to III‐IV	<0.0001^**
Location, compared among tumors with different locations	0.1031
Epilepsy, presurgical epilepsy compared to nonepilepsy	0.0494^*
TRIB2 expression, high compared to Low	0.0002^**
MAP3K1 expression, high compared to Low	0.0001^**
Coexpression of TRIB2 and MAP3K1, TRIB2^High/MAP3K1High compared to others	0.0054^**

P < 0.05

^**

P < 0.01